tumor-infiltrating lymphocyte therapy

Iovance looks to advance its non-small cell lung cancer therapy
Clinical Trials Arena
Tue, 07/11/23 - 10:17 am
Iovance Biotherapeutics
clinical trials
tumor-infiltrating lymphocyte therapy
non-small cell lung cancer
lifileucel